P1645: IMPACT OF VON WILLEBRAND FACTOR AND ADAMTS13 ON CARDIOVASCULAR COMPLICATIONS AND BLEEDING IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION AND NORMAL SINUS RHYTHM CONTROLS: 10 YEARS FOLLOW UP.

• Waldemar Wysokinski,
• Danielle Vlazny,
• Robert Mcbane,
• Naser Ammash,
• Damon Houghton,
• Matylda Mazur,
• Ana Casanegra,
• Jozef Mruk,
• Diane Grill,
• Joshua Slusser,
• Rowlens Melduni

Affiliations

Waldemar Wysokinski

1 Mayo Clinic, Vascular Medicine, Rochester, United States

Danielle Vlazny

2 Cardiovascular Diseases, Vascular Medicine

Robert Mcbane

3 Cardiovascular Diseases, Cardiology

Naser Ammash

4 Cardiovascular Diseases, Cardiology, Rochester, United States

Damon Houghton

5 Cardiovascular Diseases, Vascular Medicine, Rochester, United States

Matylda Mazur

4 Cardiovascular Diseases, Cardiology, Rochester, United States

Ana Casanegra

5 Cardiovascular Diseases, Vascular Medicine, Rochester, United States

Jozef Mruk

3 Cardiovascular Diseases, Cardiology

Diane Grill

6 Mayo Clinic, Clinical Trials and Biostatistics

Joshua Slusser

6 Mayo Clinic, Clinical Trials and Biostatistics

Rowlens Melduni

3 Cardiovascular Diseases, Cardiology